Ala-Ak-Ct019
ClinicalTrials.gov NCT05662202
Research payments
$739,638
Through program year 2024, $739,638 in research payments was reported against Ala-Ak-Ct019, across 71 payments, paid by Biofrontera Bioscience GmbH.
- Paid by
- Biofrontera Bioscience GmbH
- ClinicalTrials.gov
- NCT05662202
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $380,612 | 51 |
| 2023 | Research | $345,386 | 18 |
| 2022 | Research | $13,640 | 2 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Edward Lain Pflugerville, TX Named on 12 payments
- John Tu Rochester, NY Named on 10 payments
- Janet DuBois Austin, TX Named on 8 payments
- Sherrif Ibrahim Victor, NY Named on 8 payments
- Jonathan Weiss Snellville, GA Named on 6 payments
- Todd Schlesinger Charleston, SC Named on 6 payments
- John Strasswimmer Delray Beach, FL Named on 5 payments
- Nathalie Zeitouni Phoenix, AZ Named on 5 payments
- Joel Cohen Greenwood Village, CO Named on 3 payments
- Sadra Jazayeri Phoenix, AZ Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.